PROBLEM: 80% of Ovarian Cancer is Fatal
VesiCure's
Solution:
Macrophage Engineered Vesicles (MEVs): The Only Effective Maintenance Therapy
MEVs are a cell-based therapy for ovarian cancer maintenance treatment.
FEATURES
MEVs are a cell-based therapy for ovarian cancer maintenance treatment
EFFECTIVE
Impressive anti-cancer activity
SAFE
No serious adverse effects
UNMET MEDICAL NEED
No serious adverse effects
PERSONALIZED
Autologous
CURRENT APPROVED OVARIAN CANCER MAINTENANCE THERAPIES
VESICURE: VALUE PROPOSITION
HEALTH CARE PROVIDERS
Improves patient outcomes
Doesn’t compete with
other modalities
HEALTH SYSTEMS
Generates outpatient revenue
Integrates into existing workflow
WOMEN WITH OVARIAN CANCER
Improved survival
No adverse effects